Star Equity Holdings, Inc (STRRP)

Etorro trading 970x250

About Star Equity Holdings, Inc

Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Suwanee, Georgia. Address: 1048 Industrial Court, Suwanee, GA, United States, 30024

Star Equity Holdings, Inc News and around…

Latest news about Star Equity Holdings, Inc (STRRP) common stock and company :

Star Equity Holdings, Inc. to Present at The Benchmark Company’s Discovery One on One Virtual Video Investor Conference on December 2
29 Nov, 2021 Yahoo! Finance

OLD GREENWICH, Conn., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company with three business divisions, Healthcare, Construction, and Investments, announced today that its management team will be presenting at The Benchmark Company’s Discovery One on One Virtual Video Investor Conference on Thursday, December 2, 2021. Star Equity’s management will be speaking with investors throughout the day, in one

Star Equity Holdings, Inc. Announces Private Placement
22 Nov, 2021 Yahoo! Finance

OLD GREENWICH, Conn., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company, announced today the Company’s intent to undertake a private placement of 650,000 shares of the Company’s common stock to Jeffrey E. Eberwein, Executive Chairman of the Company. The proposed private placement was approved by a Special Committee made up of independent directors and the Audit Committee of the Board of Directors of

Star Equity Holdings, Inc. Declares Cash Dividends Totaling $1.806 Per Share of 10% Series A Cumulative Perpetual Preferred Stock
22 Nov, 2021 Yahoo! Finance

OLD GREENWICH, Conn., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified industry holding company, announced today that its Board of Directors (the “Board”) declared a cash dividend to holders of the Company’s 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is December 1, 2021, and the payment date is December 10, 2021. The Board has also declared a cash dividen

Star Equity Holdings, Inc. Announces 2021 Third Quarter Financial Results
12 Nov, 2021 Yahoo! Finance

Q3 2021 revenues increased 64.5% in Construction and 16.1% in HealthcareNet debt decreased by $10.6 million versus a year ago OLD GREENWICH, Conn., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company, reported today its financial results for the third quarter (Q3) and nine months (9M) ended September 30, 2021. Following the sale of DMS Health Technologies, Inc. (“DMS Health”) for $18.75 million and the

Star Equity Holdings, Inc. to Release Third Quarter 2021 Financial Results on November 12
04 Nov, 2021 Yahoo! Finance

OLD GREENWICH, Conn., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP), (“Star Equity” or the “Company”), a diversified holding company, announced today that it will release its financial results for the third quarter ended September 30, 2021, before the market opens on Friday, November 12, 2021. A conference call is scheduled for 11:00 a.m. ET (8:00 a.m. PT) on November 12, 2021, to discuss the results and management’s outlook. The call may be accessed by diali

Analysts Expect Star Equity Holdings, Inc. (NASDAQ:STRR) To Breakeven Soon
21 Sep, 2021 Yahoo! Finance

We feel now is a pretty good time to analyse Star Equity Holdings, Inc.'s ( NASDAQ:STRR ) business as it appears the...

Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock
16 Aug, 2021 Yahoo! Finance

OLD GREENWICH, Conn., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, announced today that its Board of Directors (the “Board”) declared a cash dividend to holders of the Company’s 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is September 1, 2021, and

Star Equity Holdings, Inc. Announces 2021 Second Quarter and Six Months Ended Financial Results
10 Aug, 2021 Yahoo! Finance

For Q2 2021, reports 57.0% and 117.2% increase in Healthcare and Construction revenues, respectively Ended Q2 2021 with $6.3 million in cash and cash equivalents OLD GREENWICH, Conn., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified, multi-industry holding company with three divisions, Healthcare, Construction, and Investments, reported today its financial results for the second quarter (Q2) and six months (6M) end

Star Equity Holdings, Inc. Appoints John Gildea to its Board of Directors
06 Aug, 2021 Yahoo! Finance

OLD GREENWICH, Conn., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, announced today the appointment of John W. Gildea to its Board of Directors, effective immediately. Mr. Gildea’s appointment as independent director expands Star Equity’s Board to six members. Mr. Gildea will also serve on the Audit Committe

Star Equity Holdings, Inc. to Release Second Quarter 2021 Financial Results on August 10
03 Aug, 2021 Yahoo! Finance

OLD GREENWICH, Conn., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, announced today that it will release its financial results for the second quarter ended June 30, 2021, before the market opens on Tuesday, August 10, 2021. A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on August 10, 2021, t

Star Equity Holdings, Inc. to Present at the Access to Giving Virtual Conference on July 15
09 Jul, 2021 Yahoo! Finance

OLD GREENWICH, Conn., July 09, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified, multi-industry holding company with three business divisions (Healthcare, Construction, and Investments), announced today that its management team will be presenting at the Access to Giving Virtual Conference, on Thursday, July 15, 2021. Star’s main presentation is scheduled for 3:30 pm ET. Investors will be able to access the presentation live over

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
08 Jul, 2021 Yahoo! Finance

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th \- 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors throughout the event.

Star Equity Holdings, Inc. Adopts Rights Agreement to Protect its Net Operating Losses
02 Jun, 2021 Yahoo! Finance

Will Submit Rights Agreement for Stockholder Approval at its 2021 Annual MeetingOLD GREENWICH, Conn., June 02, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, announced today that its Board of Directors (the “Board”) has adopted, and the Company has entered into, a Rights Agreement (the “Rights Agreement”) with America

Sidoti Microcap Virtual Conference
18 May, 2021 Yahoo! Finance

May 19 - 20, 2021Presentation times and weblinks released for over 60 presenting companiesNEW YORK, NY / ACCESSWIRE / May 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day spring Microcap Virtual Conference taking place Wednesday and Thursday, May 19 - 20, 2021. The links can also be found at www.

Star Equity Holdings, Inc. to Present at the Sidoti Virtual Microcap Conference on May 20th
17 May, 2021 Yahoo! Finance

OLD GREENWICH, Conn., May 17, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings (Nasdaq: STRR; STRRP) (“Star” or the “Company”), a diversified, multi-industry holding company with three business divisions (Healthcare, Construction, and Investments), announced today that its management team will be presenting at the Sidoti Virtual Microcap Conference, on Thursday, May 20, 2021. Star’s main presentation is scheduled for 11:30 am ET, at Virtual Estate Room #1. Investors will be able to access the presentation live over the Internet via the weblink: https://sidoti.zoom.us/webinar/register/WN_V5UJmXFUTuu-g0vMRUZk7w. Additionally, Star’s management will be speaking with investors throughout the day. Investors can download a PDF copy of the presentation by visiting Star’s Investor Relations section of the website: www.starequity.com. About Star Equity Holdings, Inc. Star Equity Holdings, Inc. is a diversified holding entity with three divisions: Healthcare, Construction, and Investments. Healthcare Our Healthcare division designs, manufactures, and distributes diagnostic medical imaging products and provides mobile imaging services. Our Healthcare division operates in two businesses: (i) diagnostic services and (ii) diagnostic imaging. The diagnostic services business offers imaging services to healthcare providers as an outsourced alternative to purchasing and operating their own equipment. The diagnostic imaging business develops, sells, and maintains solid-state gamma cameras. Construction Our Construction division manufactures modular housing units for commercial and residential real estate projects and operates in two businesses: (i) modular building manufacturing and (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations for professional builders. Investments Our Investments division manages and finances the Company’s real estate assets and investments. Forward-Looking Statements“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this release that are not statements of historical fact are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking Statements include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to acquisitions and related integration, development of commercially viable products, novel technologies, and modern applicable services, (ii) projections of income (including income/loss), EBITDA, earnings (including earnings/loss) per share, free cash flow (FCF), capital expenditures, cost reductions, capital structure or other financial items, (iii) the future financial performance of the Company or acquisition targets and (iv) the assumptions underlying or relating to any statement described above. Moreover, forward-looking statements necessarily involve assumptions on the Company’s part. These forward-looking statements generally are identified by the words “believe”, “expect”, “anticipate”, “estimate”, “project”, “intend”, “plan”, “should”, “may”, “will”, “would”, “will be”, “will continue” or similar expressions. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described above as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the substantial amount of debt of the Company and the Company’s ability to repay or refinance it or incur additional debt in the future; the Company’s need for a significant amount of cash to service and repay the debt and to pay dividends on the Company’s preferred stock; the restrictions contained in the debt agreements that limit the discretion of management in operating the business; legal, regulatory, political and economic risks in markets and public health crises that reduce economic activity and cause restrictions on operations (including the recent coronavirus COVID-19 outbreak); the length of time associated with servicing customers; losses of significant contracts or failure to get potential contracts being discussed; disruptions in the relationship with third party vendors; accounts receivable turnover; insufficient cash flows and resulting lack of liquidity; the Company's inability to expand the Company's business; unfavorable changes in the extensive governmental legislation and regulations governing healthcare providers and the provision of healthcare services and the competitive impact of such changes (including unfavorable changes to reimbursement policies); high costs of regulatory compliance; the liability and compliance costs regarding environmental regulations; the underlying condition of the technology support industry; the lack of product diversification; development and introduction of new technologies and intense competition in the healthcare industry; existing or increased competition; risks to the price and volatility of the Company’s common stock and preferred stock; stock volatility and in liquidity; risks to preferred stockholders of not receiving dividends and risks to the Company’s ability to pursue growth opportunities if the Company continues to pay dividends according to the terms of the Company’s preferred stock; the Company’s ability to execute on its business strategy (including any cost reduction plans); the Company’s failure to realize expected benefits of restructuring and cost-cutting actions; the Company’s ability to preserve and monetize its net operating losses; risks associated with the Company’s possible pursuit of acquisitions; the Company’s ability to consummate successful acquisitions and execute related integration, as well as factors related to the Company’s business including economic and financial market conditions generally and economic conditions in the Company’s markets; failure to keep pace with evolving technologies and difficulties integrating technologies; system failures; losses of key management personnel and the inability to attract and retain highly qualified management and personnel in the future; and the continued demand for and market acceptance of the Company’s services. For a detailed discussion of cautionary statements and risks that may affect the Company’s future results of operations and financial results, please refer to the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the risk factors in the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. This release reflects management’s views as of the date presented. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. For more information contact: Star Equity Holdings, Inc.The Equity GroupJeffrey E. EberweinLena CatiExecutive ChairmanVice President203-489-9501212-836-9611admin@starequity.comlcati@equityny.com

Star Equity Holdings, Inc. to Host Earnings Call
14 May, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / May 14, 2021 / Star Equity Holdings, Inc. (NASDAQ:STRR) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 14, 2021 at 10:00 AM Eastern Time.

Star Equity Holdings, Inc. Announces 2021 First Quarter Financial Results
14 May, 2021 Yahoo! Finance

Sale of assets substantially improved balance sheetConstruction revenue grew 65% OLD GREENWICH, CT, May 14, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star” or the “Company”), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, reported today its financial results for the first quarter (Q1) ended March 31, 2021. During Q1 2021, the Company completed the sale of its DMS Health Technologies, Inc. (“DMS Health”) business unit for $18.75 million and the sale of another small business for $1.4 million. Financial results for both the Q1 2021 and 2020 reporting periods relate to continuing operations, which encompass Healthcare (Diagnostic Services and Diagnostic Imaging), Construction, and Investments. Q1 2021 Financial Highlights vs. Q1 2020 (unaudited)* Total revenues from continuing operations increased 16.5% to $22.4 million from $19.2 millionGross profit from continuing operations decreased to $3.1 million from $3.2 millionNet loss from continuing operations was $0.6 million (or $0.12 per basic and diluted share) compared to a net loss from continuing operations of $2.4 million (or $1.15 per basic and diluted share) *Non-GAAP adjusted EBITDA from continuing operations decreased to $(0.9) million from $(0.5) millionAs of March 31, 2021, cash and cash equivalents and restricted cash increased to $13.3 million from $1.6 million and net debt decreased to $3.5 million from $20.4 million * On May 28, 2020, Star completed a public offering through in which the Company issued and sold 2,225,000 shares of its common stock and 2,225,000 warrants to purchase up to 1,112,500 additional shares of common stock. As of March 31, 2021, 0.9 million of these warrants had been exercised for the issuance of an additional 0.5 million shares of our common stock at an exercise price of $2.25. Per share amounts for Q1 2021 period, reflect the new share count. Jeff Eberwein, Executive Chairman of Star, noted, “In Q1 2021, our Healthcare division continued to be impacted by the COVID-19 pandemic with revenue declining slightly versus the prior year quarter. Activity levels continue to rebound toward pre-COVID levels. Our Construction division grew revenue by 65% with much of the growth attributable to significantly increased output at our KBS business. Gross margin percentage at our Construction division declined as a consequence of rising raw materials prices, but is expected to return to more normal levels in the coming quarters.” Mr. Eberwein continued, “The asset sales completed in Q1 2021 substantially improved our balance sheet and liquidity position with net debt decreasing from $20.4 million a year ago to $3.5 million at the end of Q1 2021. We are now better positioned to fund high-return internal growth investments and pursue acquisitions, which could be bolt-ons in Healthcare or Construction or entry into a new business sector.” Revenues The Company’s total Q1 2021 revenues from continuing operations increased 16.5% to $22.4 million from $19.2 million in the first quarter of the prior year. Revenues in $ thousands Q1 2021 Q1 2020 % changeHealthcare $13,307 $13,675 (2.7)%Construction 9,047 5,484 65.0%Investments — 31 (100.0)%Total Revenues $22,354 $19,190 16.5% Although Q1 2021 revenues for the Healthcare division decreased slightly from Q1 2020, this division has largely recovered from the COVID pandemic related downturn and is now performing at near pre-pandemic levels. Doctor offices have reopened but are not yet operating at full capacity. As state-by-state vaccination levels increase, we expect volumes to increase and our operations fully return to normal levels later this year. The increase in revenues for the Construction division was mainly due to higher production levels at KBS, with $2.7 million in revenue recognized on a large commercial project. Gross Profit Gross profit in $ thousands Q1 2021 Q1 2020 % changeHealthcare $2,598 $2,874 (9.6)%Healthcare gross margin 19.5% 21.0% (1.5)%Construction 544 403 35.0%Construction gross margin 6.0% 7.3% (1.3)%Investments (65) (34) 91.2%Total gross profit $3,077 $3,243 (5.1)%Total gross margin 13.8% 16.9% Q1 2021 gross profit for the Healthcare division decreased by 9.6% from the prior year’s quarter due to the continued impact of the COVID-19 pandemic. Although revenues only decreased by 2.7%, gross profit declined by a higher percentage because some costs remained fairly constant such as employee costs, insurance, workers compensation, rents, utilities, and repairs and maintenance. Q1 2021 gross profit for the Construction division increased by 35.0% from the prior year’s quarter due to increased production activity from recently won commercial projects. Gross margin percentage in Q1 2021 was adversely impacted by a rise in raw materials prices. We increased prices at the beginning of 2021 to offset these higher input costs, and our backlog remains very strong. We expect gross margins in Construction to improve over time. Operating Expenses Q1 2021 sales, general and administrative (SG&A) expenses increased by 3.9%, or $0.2 million from the prior year period, primarily due to a $0.3 million increase in the Construction business as a result of increased commissions and headcount, offset by $0.1 million reduced travel expense in the Healthcare division. Non-GAAP Adjusted EBITDA Q1 2021 non-GAAP adjusted EBITDA from continuing operations decreased to negative $0.9 million from negative $0.5 million in the same quarter of the prior year due to a rise in raw materials prices in Construction and decrease in gross profit due to the continued impact of the COVID-19 pandemic in Healthcare. Net Loss Q1 2021 net loss from continuing operations was $0.6 million, or $0.12 per basic and diluted share, compared to net loss of $2.4 million, or $1.15 per basic and diluted share, in the same period in the prior year. Q1 2021 non-GAAP adjusted net loss from continuing operations was $1.7 million, or $0.35 per basic and diluted share, compared to adjusted net loss from continuing operations of $1.3 million, or $0.65 per basic and diluted share, in the prior year period. Operating cash flow Q1 2021 cash flow from operations was an outflow of $2.2 million, compared to an inflow of $0.6 million for the same period in the prior year due to increased investment in working capital to fund the revenue growth in the Construction division. Conference Call Information A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on May 14, 2021 to discuss the results and management’s outlook. The call may be accessed by dialing 1-877-407-9039 (international callers: +1-201-689-8470) five minutes prior to the scheduled start time and referencing Star. A simultaneous webcast of the call may be accessed online from the Events & Presentations link on the Investor Relations page at starequity.com/events-and-presentations/presentations; an archived replay of the webcast will be available within 15 minutes of the end of the conference call. If you have any questions, either prior to or after our scheduled Earnings Conference call, please e-mail admin@starequity.com or lcati@equityny.com. Use of Non-GAAP Financial Measures by Star Equity Holdings, Inc. This release presents the non-GAAP financial measures “adjusted net income (loss),” “adjusted net income (loss) per basic and diluted share,” “adjusted cash earnings per share”, and “adjusted EBITDA from continuing operations.” The most directly comparable measure for these non-GAAP financial measures are “net income and basic and diluted net income per share”, and “cash flows from operating activities”. The Company has included below unaudited adjusted financial information, which presents the Company’s results of operations after excluding acquired intangible asset amortization, one time transaction costs, financing costs, gain or loss from the early retirement of debt, litigation costs, COVID-19 protection equipment, unrealized gain (loss) on available-for-sale securities, non-recurring gain on disposals, non-recurring costs related to sales and use tax and income tax adjustments. Further excluded in the measure of adjusted EBITDA are interest, taxes, depreciation, amortization, and stock-based compensation. A discussion of the reasons why management believes that the presentation of non-GAAP financial measures provides useful information to investors regarding Star’s financial condition and results of operations is included as Exhibit 99.2 to Star’s report on Form 8-K filed with the Securities and Exchange Commission on May 14, 2021. About Star Equity Holdings, Inc. Star Equity Holdings, Inc. is a diversified holding entity with three divisions: Healthcare, Construction, and Investments. Healthcare Our Healthcare division designs, manufactures, and distributes diagnostic medical imaging products and provides mobile imaging services. Our Healthcare division operates in two businesses: (i) diagnostic services and (i) diagnostic imaging. The diagnostic services business offers imaging services to healthcare providers as an outsourced alternative to purchasing and operating their own equipment. The diagnostic imaging business develops, sells, and maintains solid-state gamma cameras. Construction Our Construction division manufactures modular housing units for commercial and residential real estate projects and operates in two businesses: (i) modular building manufacturing and (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations for professional builders. Investments Our Investments division manages and finances the Company’s real estate assets and investments. Forward-Looking Statements “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this release that are not statements of historical fact are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking Statements include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to acquisitions and related integration, development of commercially viable products, novel technologies, and modern applicable services, (ii) projections of income (including income/loss), EBITDA, earnings (including earnings/loss) per share, free cash flow (FCF), capital expenditures, cost reductions, capital structure or other financial items, (iii) the future financial performance of the Company or acquisition targets and (iv) the assumptions underlying or relating to any statement described above. Moreover, forward-looking statements necessarily involve assumptions on the Company’s part. These forward-looking statements generally are identified by the words “believe”, “expect”, “anticipate”, “estimate”, “project”, “intend”, “plan”, “should”, “may”, “will”, “would”, “will be”, “will continue” or similar expressions. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described above as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the substantial amount of debt of the Company and the Company’s ability to repay or refinance it or incur additional debt in the future; the Company’s need for a significant amount of cash to service and repay the debt and to pay dividends on the Company’s preferred stock; the restrictions contained in the debt agreements that limit the discretion of management in operating the business; legal, regulatory, political and economic risks in markets and public health crises that reduce economic activity and cause restrictions on operations (including the recent coronavirus COVID-19 outbreak); the length of time associated with servicing customers; losses of significant contracts or failure to get potential contracts being discussed; disruptions in the relationship with third party vendors; accounts receivable turnover; insufficient cash flows and resulting lack of liquidity; the Company's inability to expand the Company's business; unfavorable changes in the extensive governmental legislation and regulations governing healthcare providers and the provision of healthcare services and the competitive impact of such changes (including unfavorable changes to reimbursement policies); high costs of regulatory compliance; the liability and compliance costs regarding environmental regulations; the underlying condition of the technology support industry; the lack of product diversification; development and introduction of new technologies and intense competition in the healthcare industry; existing or increased competition; risks to the price and volatility of the Company’s common stock and preferred stock; stock volatility and in liquidity; risks to preferred stockholders of not receiving dividends and risks to the Company’s ability to pursue growth opportunities if the Company continues to pay dividends according to the terms of the Company’s preferred stock; the Company’s ability to execute on its business strategy (including any cost reduction plans); the Company’s failure to realize expected benefits of restructuring and cost-cutting actions; the Company’s ability to preserve and monetize its net operating losses; risks associated with the Company’s possible pursuit of acquisitions; the Company’s ability to consummate successful acquisitions and execute related integration, as well as factors related to the Company’s business including economic and financial market conditions generally and economic conditions in the Company’s markets; failure to keep pace with evolving technologies and difficulties integrating technologies; system failures; losses of key management personnel and the inability to attract and retain highly qualified management and personnel in the future; and the continued demand for and market acceptance of the Company’s services. For a detailed discussion of cautionary statements and risks that may affect the Company’s future results of operations and financial results, please refer to the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the risk factors in the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. This release reflects management’s views as of the date presented. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. For more information contact: Star Equity Holdings, Inc.The Equity Group Jeffrey E. EberweinLena Cati Executive ChairmanVice President 203-489-9501212-836-9611 admin@starequity.comlcati@equityny.com (Financial tables follow) Star Equity Holdings, Inc.Condensed Consolidated Statements of Operations(Unaudited)(In thousands, except for per share amounts) Three Months Ended March 31, 2021 2020Revenues: Healthcare $13,307 $13,675 Construction 9,047 5,484 Investments — 31 Total revenues 22,354 19,190 Cost of revenues: Healthcare 10,709 10,801 Construction 8,503 5,081 Investments 65 65 Total cost of revenues 19,277 15,947 Gross profit 3,077 3,243 Operating expenses: Selling, general and administrative 5,055 4,863 Amortization of intangible assets 438 576 Gain on sale of MD Office Solutions (847) — Total operating expenses 4,646 5,439 Loss from operations (1,569) (2,196)Other income (expense): Other income, net 1,255 160 Interest expense, net (272) (305)Total other income (expense) 983 (145)Loss from continuing operations before income taxes (586) (2,341)Income tax expense (2) (27)Loss from continuing operations, net of tax (588) (2,368)Income (loss) from discontinued operations, net of tax 6,020 (585)Net income (loss) 5,432 (2,953)Deemed dividend on Series A redeemable preferred stock (479) (484)Net income (loss) attributable to common shareholders $4,953 $(3,437) Net income (loss) per share—basic and diluted Net loss per share, continuing operations $(0.12) $(1.15)Net income (loss) per share, discontinued operations $1.22 $(0.28)Net income (loss) per share—basic and diluted $1.10 $(1.44)Deemed dividend on Series A cumulative perpetual preferred stock per share $(0.10) $(0.24)Net income (loss) per share, attributable to common shareholders—basic and diluted: $1.01 $(1.67)Weighted-average shares outstanding—basic and diluted 4,916 2,055 Star Equity Holdings, Inc.Condensed Consolidated Balance Sheets (Unaudited) (In thousands, except share amounts) March 31,2021 December 31,2020Assets: Current assets: Cash and cash equivalents $13,175 $3,225 Restricted cash 168 168 Accounts receivable, net 14,886 12,975 Inventories, net 9,838 9,787 Other current assets 2,738 2,025 Assets held for sale — 20,756 Total current assets 40,805 48,936 Property and equipment, net 9,383 9,762 Operating lease right-of-use assets 2,848 1,769 Intangible assets, net 16,362 16,900 Goodwill 9,405 9,542 Other assets 2,588 1,384 Total assets $81,391 $88,293 Liabilities, Mezzanine Equity and Stockholders’ Equity: Current liabilities: Accounts payable $5,535 $4,952 Accrued compensation 3,695 2,825 Accrued warranty 180 214 Deferred revenue 2,352 2,184 Short-term debt and current portion of long-term debt 12,548 18,362 Payable to related parties 2,307 2,307 Operating lease liabilities, current portion 1,075 1,011 Other current liabilities 2,859 3,000 Liabilities held for sale — 7,871 Total current liabilities 30,551 42,726 Long-term debt, net of current portion 1,967 3,700 Deferred tax liabilities 51 51 Operating lease liabilities, net of current portion 1,824 828 Other liabilities 1,018 1,059 Total liabilities 35,411 48,364 Preferred stock, $0.0001 par value: 10,000,000 shares authorized: 10% Series A Cumulative Redeemable preferred stock, 8,000,000 shares authorized, liquidation preference ($10.00 per share), 1,915,637 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 21,979 21,500 Stockholders’ equity: Common stock, $0.0001 par value: 30,000,000 shares authorized; 5,020,969 and 4,798,367 shares issued and outstanding (net of treasury shares) at March 31, 2021 and December 31, 2020, respectively — — Treasury stock, at cost; 258,849 shares at March 31, 2021 and December 31, 2020, respectively (5,728) (5,728)Additional paid-in capital 149,283 149,143 Accumulated deficit (119,554) (124,986)Total stockholders’ equity 24,001 18,429 Total liabilities, mezzanine equity and stockholders’ equity $81,391 $88,293 Star Equity Holdings, Inc.Reconciliation of Non-GAAP Financial Measures(Unaudited)(In thousands, except per share amounts) Three Months Ended March 31, 2021 2020 Net loss from continuing operations $(588) $(2,368)Acquired intangible amortization 438 576 Unrealized gain on equity securities (1) (23) 26 Litigation costs (2) 2 160 MDOS gain (3) (847) — Tenant receivable (4) 323 — Write-off of Star Real Estate Holding assets — 135 Transaction cost (5) — 115 Financing cost (6) 132 — COVID -19 Protection Equipment (7) 38 — SBA PPP Loan forgiveness (8) (1,220) — Income tax expense 2 27 Non-GAAP adjusted net loss from continuing operations $(1,743) $(1,329) Net loss per diluted share from continuing operations $(0.12) $(1.15)Acquired intangible amortization 0.09 0.28 Unrealized gain on equity securities (1) — 0.01 Litigation costs (2) — 0.08 MDOS gain (3) (0.17) — Tenant receivable (4) 0.07 — Write-off of Star Real Estate Holding assets — 0.07 Transaction cost (5) — 0.06 Financing cost (6) 0.03 — COVID -19 Protection Equipment (7) 0.01 — SBA PPP Loan forgiveness (8) (0.25) — Income tax expense — 0.01 Non-GAAP adjusted net loss per basic and diluted share from continuing operations (9) $(0.35) $(0.65) (1) Reflects change in fair value of investments in equity securities.(2) Reflects one time litigation costs.(3) Reflects the gain from the sale of MDOS.(4) Reflects one time write off in uncollectible tenant receivable.(5) Reflects legal and other costs related to the ATRM merger and holding company conversion.(6) Reflects financing costs from our credit facilities.(7) Reflects purchases related to COVID -19 Protection Equipment.(8) Reflects the forgiveness of the Paycheck Protection Program.(9) Per share amounts are computed independently for each discrete item presented. Therefore, the sum of the quarterly per share amounts will not necessarily equal to the total for the year, and sum of individual items may not equal the total. Star Equity Holdings, Inc.Reconciliation of Non-GAAP Financial Measures(Unaudited)(In thousands) For The Three Months Ended March 31, 2021 DiagnosticServices DiagnosticImaging Construction Investments Star EquityCorporate Total Net income (loss) from continuing operations $877 $(232) $(354) $(83) $(796) $(588)Depreciation and amortization 290 67 479 65 — 901 Interest expense 18 57 197 — — 272 Income tax expense 2 — — — — 2 EBITDA from continuing operations 1,187 (108) 322 (18) (796) 587 Unrealized gain on equity securities (1) — — — — (23) (23)Litigation costs (2) — — — — 2 2 Stock-based compensation 29 49 — — 51 129 MDOS gain (3) (847) — — — — (847)Tenant receivable (4) — — 323 — — 323 Financing cost (6) — 42 90 — — 132 COVID-19 Protection Equipment (7) 36 2 — — — 38 SBA PPP Loan forgiveness (8) — — (1,220) — — (1,220)Non-GAAP adjusted EBITDA from continuing operations $405 $(15) $(485) $(18) $(766) $(879) For The Three Months Ended March 31, 2020 DiagnosticServices DiagnosticImaging Construction Investments Star EquityCorporate Total Net income (loss) from continuing operations $75 $147 $(1,503) $(52) $(1,035) $(2,368)Depreciation and amortization 329 63 572 65 — 1,029 Interest expense 20 26 259 — — 305 Income tax expense — 26 1 — — 27 EBITDA from continuing operations 424 262 (671) 13 (1,035) (1,007) Unrealized gain on equity securities (1) — — — — 26 26 Litigation costs (2) — — — — 160 160 Stock-based compensation 34 60 — — 12 106 Write off of Star Real Estate Holding Assets — — — — 135 135 Transaction cost (5) — — — — 115 115 Non-GAAP adjusted EBITDA from continuing operations $458 $322 $(671) $13 $(587) $(465) (1) Reflects change in fair value of investments in equity securities.(2) Reflects one time litigation costs.(3) Reflects the gain from the sale of MDOS.(4) Reflects one time write off in uncollectible tenant receivable.(5) Reflects legal and other costs related to the ATRM merger and holdings company conversion.(6) Reflects financing costs from our credit facilities.(7) Reflects purchases related to COVID -19 Protection Equipment.(8) Reflects the forgiveness of the Paycheck Protection Program. Star Equity Holdings, Inc.Supplemental Debt Information(Unaudited)(In thousands) A summary of the Company’s credit facilities and related party notes are as follows: March 31, 2021 December 31, 2020 Amount Weighted-Average Interest Rate Amount Weighted-Average Interest RateRevolving Credit Facility - Gerber KBS $2,672 6.00% $1,099 6.00%Revolving Credit Facility - Gerber EBGL 1,969 6.00% 2,016 6.00%Revolving Credit Facility - SNB 5,000 2.61% 12,710 2.64%Total Short-term Revolving Credit Facility $9,641 4.24% $15,825 3.30%Gerber - Star Term Loan $271 6.25% $262 6.75%Premier - Term Loan 335 5.75% 419 5.75%Total Short Term Debt $606 5.97% $681 6.13%Short-term Paycheck Protection Program Notes $2,301 1.00% $1,856 1.00%Short-term debt and current portion of long-term debt $12,548 3.73% $18,362 3.17% Gerber - Star Term Loan $985 6.25% $1,058 6.75%Premier - Term Loan 324 5.75% 321 5.75%Total Long Term Debt $1,309 6.13% $1,379 6.52%Long-term Paycheck Protection Program Notes $658 1.00% $2,321 1.00%Long-term debt, net of current portion $1,967 4.41% $3,700 3.06% LSV Co-Invest I Promissory Note (“January Note”) $709 12.00% $709 12.00%LSV Co-Invest I Promissory Note (“June Note”) 1,220 12.00% 1,220 12.00%LSVM Note 378 12.00% 378 12.00%Total Notes Payable To Related Parties $2,307 12.00% $2,307 12.00% Total Debt $16,822 4.94% $24,369 3.99% Term Loan Facilities The following table presents the Star and Premier term loans balance net of unamortized debt issuance costs as of March 31, 2021 (in thousands): March 31, 2021 AmountGerber - Star Term Loan $1,533 Premier - Term Loan 659 Total Principal 2,192 Unamortized debt issuance costs (277) Total $1,915 Star Equity Holdings, Inc.Supplemental Segment Information(Unaudited)(In thousands) Three Months Ended March 31, 2021 2020Revenue by segment: Diagnostic Services $10,239 $10,814 Diagnostic Imaging 3,068 2,861 Construction 9,047 5,484 Investments — 31 Consolidated revenue $22,354 $19,190 Gross profit by segment: Diagnostic Services $1,608 $2,005 Diagnostic Imaging 990 869 Construction 544 403 Investments (65) (34)Consolidated gross profit $3,077 $3,243 Income (loss) from continuing operations by segment: Diagnostic Services $859 $59 Diagnostic Imaging (22) (267)Construction (1,547) (1,300)Investments 76 (54)Star Corporate expenses (935) (634)Segment loss from operations $(1,569) $(2,196) Depreciation and amortization by segment: Diagnostic Services $290 $329 Diagnostic Imaging 67 63 Construction 479 572 Investments 65 65 Total depreciation and amortization $901 $1,029

Star Equity Holdings, Inc. to Release First Quarter 2021 Financial Results on May 14
05 May, 2021 Yahoo! Finance

OLD GREENWICH, Conn., May 05, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified, multi-industry holding company with three business divisions (Healthcare, Construction, and Investments), announced today that it will release its financial results for the first quarter ended March 31, 2021, before the market opens on Friday, May 14, 2021. A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on May 14, 2021 to discuss the results and management’s outlook. The call may be accessed by dialing 1-877-407-9039 (international callers +1-201-689-8470). A simultaneous webcast of the call may be accessed online from the Events & Presentations link, on the Investor Relations page of the Star website at: https://www.starequity.com/events-and-presentations/presentations. An archived replay of the webcast will be available within 15 minutes of the end of the conference call. About Star Equity Holdings, Inc.Star Equity Holdings, Inc. is a diversified holding entity with three divisions: Healthcare, Construction, and Investments. HealthcareDigirad Health designs, manufactures, and distributes diagnostic medical imaging products and provides mobile imaging services. Digirad Health operates in two businesses: (i) diagnostic services and (i) diagnostic imaging. The diagnostic services business offers imaging services to healthcare providers as an outsourced alternative to purchasing and operating their own equipment. The diagnostic imaging business develops, sells, and maintains solid-state gamma cameras. ConstructionStar Modular Construction manufactures modular housing units for commercial and residential real estate projects and operates in two businesses: (i) modular building manufacturing and (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations for professional builders. InvestmentsStar Investments manages and finances the Company’s real estate assets and investments. Forward-Looking Statements“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this release that are not statements of historical fact are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking Statements include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to acquisitions and related integration, development of commercially viable products, novel technologies, and modern applicable services, (ii) projections of income (including income/loss), EBITDA, earnings (including earnings/loss) per share, free cash flow (FCF), capital expenditures, cost reductions, capital structure or other financial items, (iii) the future financial performance of the Company or acquisition targets and (iv) the assumptions underlying or relating to any statement described above. Moreover, forward-looking statements necessarily involve assumptions on the Company’s part. These forward-looking statements generally are identified by the words “believe”, “expect”, “anticipate”, “estimate”, “project”, “intend”, “plan”, “should”, “may”, “will”, “would”, “will be”, “will continue” or similar expressions. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described above as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the substantial amount of debt of the Company and the Company’s ability to repay or refinance it or incur additional debt in the future; the Company’s need for a significant amount of cash to service and repay the debt and to pay dividends on the Company’s preferred stock; the restrictions contained in the debt agreements that limit the discretion of management in operating the business; legal, regulatory, political and economic risks in markets and public health crises that reduce economic activity and cause restrictions on operations (including the recent coronavirus COVID-19 outbreak); the length of time associated with servicing customers; losses of significant contracts or failure to get potential contracts being discussed; disruptions in the relationship with third party vendors; accounts receivable turnover; insufficient cash flows and resulting lack of liquidity; the Company's inability to expand the Company's business; unfavorable changes in the extensive governmental legislation and regulations governing healthcare providers and the provision of healthcare services and the competitive impact of such changes (including unfavorable changes to reimbursement policies); high costs of regulatory compliance; the liability and compliance costs regarding environmental regulations; the underlying condition of the technology support industry; the lack of product diversification; development and introduction of new technologies and intense competition in the healthcare industry; existing or increased competition; risks to the price and volatility of the Company’s common stock and preferred stock; stock volatility and in liquidity; risks to preferred stockholders of not receiving dividends and risks to the Company’s ability to pursue growth opportunities if the Company continues to pay dividends according to the terms of the Company’s preferred stock; the Company’s ability to execute on its business strategy (including any cost reduction plans); the Company’s failure to realize expected benefits of restructuring and cost-cutting actions; the Company’s ability to preserve and monetize its net operating losses; risks associated with the Company’s possible pursuit of acquisitions; the Company’s ability to consummate successful acquisitions and execute related integration, as well as factors related to the Company’s business including economic and financial market conditions generally and economic conditions in the Company’s markets; failure to keep pace with evolving technologies and difficulties integrating technologies; system failures; losses of key management personnel and the inability to attract and retain highly qualified management and personnel in the future; and the continued demand for and market acceptance of the Company’s services. For a detailed discussion of cautionary statements and risks that may affect the Company’s future results of operations and financial results, please refer to the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the risk factors in the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. This release reflects management’s views as of the date presented. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. For more information contact: Star Equity Holdings, Inc.The Equity GroupJeffrey E. EberweinLena CatiExecutive ChairmanVice President203-489-9501212-836-9611admin@starequity.comlcati@equityny.com

Star Equity Holdings Completes Sale of DMS Health for $18.75 Million
01 Apr, 2021 Yahoo! Finance

OLD GREENWICH, Conn., April 01, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company with three divisions: Healthcare, Construction, and Investments, announced today the completion of the sale of DMS Health Technologies, Inc. (“DMS Health”), the Company’s Mobile Healthcare business, for $18.75 million in cash, as originally announced on November 3, 2020. Matt Molchan, CEO of Digirad Health, Inc., the Company’s Healthcare division, said, “Following the divestiture of DMS Health and another small asset sale completed on February 1, 2021 for $1.4 million, we have now streamlined our portfolio of healthcare assets and services by focusing our efforts on lower capex, higher margin segments within our Healthcare division. Our sales team is now focused on new opportunities to expand our client base and geographic footprint for selling and servicing our Digirad branded solid-state imaging cameras and on-site camera rental services.” Jeff Eberwein, Star Equity’s Executive Chairman, noted, “The sale of assets in Q1 2021 has substantially improved our balance sheet and enables us to fund high-return internal growth investments as well as pursue acquisitions which could be bolt-ons in Healthcare or Construction or entry into a new business sector.” About Star Equity Holdings, Inc.Star Equity Holdings, Inc. is a diversified holding entity with three divisions: Healthcare, Construction, and Investments. Healthcare Digirad Health designs, manufactures, and distributes diagnostic medical imaging products and provides mobile imaging services. Digirad Health operates in two businesses: (i) diagnostic services and (ii) diagnostic imaging. The diagnostic services business offers imaging services to healthcare providers as an outsourced alternative to purchasing and operating their own equipment. The diagnostic imaging business develops, sells, and maintains solid-state gamma cameras. ConstructionStar Modular Construction manufactures modular housing units for commercial and residential real estate projects and operates in two businesses: (i) modular building manufacturing and (ii) structural wall panel and wood foundation manufacturing, including building supply retail operations. InvestmentsStar Investments manages and finances the Company’s real estate assets and investments. Forward-Looking Statements“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this release that are not statements of historical fact are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking Statements include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to acquisitions and related integration, development of commercially viable products, novel technologies, and modern applicable services, (ii) projections of income (including income/loss), EBITDA, earnings (including earnings/loss) per share, free cash flow (FCF), capital expenditures, cost reductions, capital structure or other financial items, (iii) the future financial performance of the Company or acquisition targets and (iv) the assumptions underlying or relating to any statement described above. Moreover, forward-looking statements necessarily involve assumptions on the Company’s part. These forward-looking statements generally are identified by the words “believe”, “expect”, “anticipate”, “estimate”, “project”, “intend”, “plan”, “should”, “may”, “will”, “would”, “will be”, “will continue” or similar expressions. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described above as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the substantial amount of debt of the Company and the Company’s ability to repay or refinance it or incur additional debt in the future; the Company’s need for a significant amount of cash to service and repay the debt and to pay dividends on the Company’s preferred stock; the restrictions contained in the debt agreements that limit the discretion of management in operating the business; legal, regulatory, political and economic risks in markets and public health crises that reduce economic activity and cause restrictions on operations (including the recent coronavirus COVID-19 outbreak); the length of time associated with servicing customers; losses of significant contracts or failure to get potential contracts being discussed; disruptions in the relationship with third party vendors; accounts receivable turnover; insufficient cash flows and resulting lack of liquidity; the Company's inability to expand the Company's business; unfavorable changes in the extensive governmental legislation and regulations governing healthcare providers and the provision of healthcare services and the competitive impact of such changes (including unfavorable changes to reimbursement policies); high costs of regulatory compliance; the liability and compliance costs regarding environmental regulations; the underlying condition of the technology support industry; the lack of product diversification; development and introduction of new technologies and intense competition in the healthcare industry; existing or increased competition; risks to the price and volatility of the Company’s common stock and preferred stock; stock volatility and in liquidity; risks to preferred stockholders of not receiving dividends and risks to the Company’s ability to pursue growth opportunities if the Company continues to pay dividends according to the terms of the Company’s preferred stock; the Company’s ability to execute on its business strategy (including any cost reduction plans); the Company’s failure to realize expected benefits of restructuring and cost-cutting actions; the Company’s ability to preserve and monetize its net operating losses; risks associated with the Company’s possible pursuit of acquisitions; the Company’s ability to consummate successful acquisitions and execute related integration, as well as factors related to the Company’s business including economic and financial market conditions generally and economic conditions in the Company’s markets; failure to keep pace with evolving technologies and difficulties integrating technologies; system failures; losses of key management personnel and the inability to attract and retain highly qualified management and personnel in the future; and the continued demand for and market acceptance of the Company’s services. For a detailed discussion of cautionary statements and risks that may affect the Company’s future results of operations and financial results, please refer to the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the risk factors in the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. This release reflects management’s views as of the date presented. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. For more information contact: Star Equity Holdings, Inc.The Equity GroupJeffrey E. EberweinLena CatiExecutive ChairmanVice President203-489-9501212-836-9611admin@starequity.comlcati@equityny.com

Are Investors Undervaluing Star Equity Holdings, Inc. (NASDAQ:STRR) By 36%?
25 Mar, 2021 Yahoo! Finance

Does the March share price for Star Equity Holdings, Inc. ( NASDAQ:STRR ) reflect what it's really worth? Today, we...

Star Equity Holdings, Inc (STRRP) is a NASDAQ Common Stock listed in , ,

970x250